Fetal lung development progresses in a sex-specific manner with male fetuses exhibiting delayed maturation. Androgens, both exogenous and endogenous, inhibit while epidermal growth factor (EGF) enhances fetal lung development. We hypothesized that one mechanism responsible for the delay in male fetal lung development is an androgen-induced delay in EGF receptor binding activity. We measured EGF binding in sex-specific fetal rabbit lung plasma membranes isolated from control fetuses (days 21, 23, 25, 27, 29, and 30 ofgestation) and from androgen-treated fetuses (days 21, 23, and 27 of gestation) that had been continuously exposed in vivo to exogenous 5a-dihydrotestosterone from day 12 through 27 of gestation. Specific binding of EGF was significantly lower in male than in female fetal lung tissue isolated from controls at day 21 of gestation. Scatchard analysis revealed that this decrease in EGF binding was associated with decreased EGF receptor density without any significant change in affinity. Prenatal exogenous androgen treatment led to decreased EGF binding in fetal rabbit lung tissue from both sexes secondary to a decrease in EGF receptor density. These findings suggest that one mechanism responsible for the delay in male fetal lung maturation is an androgen-induced delay in EGF receptor binding activity during fetal lung development. (J. Clin. Invest. 1993. 91:425-431.)
Introduction
Epidermal growth factor (EGF)' is a 6-kD polypeptide hormone involved in the regulation of growth, development, and differentiation in the fetus ( 1 ) . EGF stimulates fetal lung maturation both in vivo: pulmonary morphology (sheep [2 ] ), compliance (rabbit [ 3 ] ), and surfactant synthesis (rabbit [4 ] ) and in vitro: surfactant phospholipid synthesis (rat fetal lung explants [ 5 ] ), fibroblast-pneumonocyte factor synthesis (mouse fetal lung fibroblasts [ 6 ] ), and surfactant-associated protein A synthesis (human fetal lung explants [ 7 ] ).
EGF mediates its effects through binding to its receptor, a 1 70-kD transmembrane glycosylated phosphoprotein with intrinsic tyrosine kinase activity (8) . EGF binding leads to the activation of the receptor's tyrosine kinase, which is essential for the receptor to function (9) . The intracellular effects of a functional EGF receptor include both autophosphorylation and the phosphorylation ofvarious substrates. These substrates function as second messengers during the process of signal transduction through which receptor binding leads to the increased transcription of specific genes, which in turn influence growth and maturation (10).
Fetal lung development progresses in a sex-specific manner with the male fetus having delayed type II cell maturation ( 11 ) . This is manifested, in the male human neonate, by both an increased incidence ( 12, 13) and severity ( 14-16) ofsurfactant deficiency disease (respiratory distress syndrome) (17) . An- drogens have been shown to delay fetal lung maturation both in vitro ( 18) and in vivo ( 19, 20) . Androgen receptors have been identified in both human (21 ) and rabbit fetal lung tissue (22) . Furthermore, in nonpulmonary tissue (rat prostate), androgens have been shown to decrease EGF receptor levels (23, 24) . We have previously shown that one of the mechanisms responsible for the sex-specific difference in rabbit fetal lung maturation is a delay in the onset of EGF activity in the male fetal lung (25) . At day 21 of gestation, female fetal lung explants but not male explants responded to EGF stimulation with increased surfactant phospholipid synthesis (25) . Furthermore, at day 21 ofgestation, the difference in plasma androgen levels (5a-dihydrotestosterone) between male and female rabbit fetuses is fivefold (26) . We hypothesized that one mechanism responsible for the male lag in fetal lung maturation would be an androgen-induced delay in EGF receptor binding activity during fetal lung development.
To test our hypothesis we performed three studies. First, we measured the ontogeny of EGF binding in sex-specific fetal rabbit lung plasma membranes isolated during fetal lung development at days 21, 23, 25, 27, 29 (27) and the lungs were removed, pooled by sex, and stored briefly at 4VC until subsequent preparation of lung plasma membranes.
Maternal androgen treatment. Osmotic pumps (model 2ML2; Alza Corp., Palo Alto, CA) containing dihydrotestosterone (5a-Androstan-17,B-ol-3-one (DHT); Steraloids, Inc., Wilton, NH) were implanted subcutaneously under sterile conditions into pregnant does on day 12 of gestation. The osmotic pumps were loaded under sterile conditions with 2 ml per pump of DHT (9 mg/ml) dissolved in dimethyl sulfoxide:glycerol (50:50). A single pump was placed into each pregnant doe via a dorsal incision using lidocaine as a local anesthetic. This concentration of DHT allowed the pumps to deliver -1 mg of DHT per day to each pregnant doe; a dose chosen from previous studies that produces female androgen levels of the same order of magnitude as those of male fetuses ( 19) . On days 21, 23, and 27 ofgestation the does were killed and the fetuses removed.
Isolation offetal lung plasma membranes. Crude lung plasma membranes were prepared from pooled fetal lung tissue using a modification ofthe method of Morishige et al. (28) . All buffer solutions used during the isolation of the lung plasma membranes contained freshly prepared protease inhibitors (leupeptin, 8 Mg/ml; soybean trypsin inhibitor, 50 gg/ml; and phenylmethylsulfonyl fluoride, 0.1 mM) (Sigma Chemical Co., St. Louis, MO) (29) . Isolation procedures were conducted at temperatures between 0 and 4VC. Fetal lung tissue was cleaned by trimming off visible bronchial tissue and then blotting the remaining tissue with filter paper to remove excess blood. The tissue was weighed and then homogenized in 5-10 vol (wt/vol) of ice cold 0.3 M sucrose buffer containing 25 mM Tris-HCl (pH 7.6) and 10mM MgCl2. The homogenate was centrifuged at 800 g for 10 min; the resulting supernatant was decanted off and then centrifuged at 20,000 g for 20 min. The pellet containing the plasma membranes was resuspended in 10-20 vol of isolation buffer (25 mM Tris-HCl, 10 mM MgCl2, pH 7.6) and centrifuged again at 20,000 g for 10 min. The final plasma membrane pellet was resuspended in 1-2 vol ofisolation buffer without protease inhibitors and stored in aliquots at -70°C until used for subsequent binding assays. Plasma membrane protein concentration was measured (30) in a total vol of 0.25 ml consisting of fetal lung plasma membranes, radiolabeled EGF, and binding buffer (128 mM NaCl, 5 mM KC1, 3 mM MgSO4, 0.9 mM CaCI2, 0.1 mM Na2HPO4, pH 7.4), 0.4% BSA, and protease inhibitors as described above (29) . The reaction was terminated by rapid vacuum filtration of the incubation mixture through a filter (GFC; Whatman Inc., Clifton, NJ) using a sampling manifold (Millipore Corp., Bedford, MA). This method rapidly separates the free radiolabeled EGF from the receptorbound which remains on the filter (31 ) . The filters were rinsed with 10 ml of binding buffer while under vacuum on the manifold, dried, and then counted for 1 min in a gamma counter. Total binding was determined by measuring the amount of radiolabeled EGF that remained bound to the fetal lung plasma membranes that were trapped on the filter. Nonspecific binding was measured as described above after preincubation ofthe membrane preparation in the presence of 500-fold excess of unlabeled EGF (Gibco Laboratories, Life Technologies, Inc., Grand Island, NY) for 10 min before the label was added. Specific binding of EGF was determined by subtracting nonspecific from total binding. Specific binding assays were performed a minimum of three times in triplicate for each gestational age except for days 29 We used a logarithmic scale for the competitor concentration (unlabeled EGF) when graphing the results of the competitive binding experiments. This was done to ensure that we had obtained binding data at ligand concentrations above the inflection point (half-maximum binding), validating our use of Scatchard analysis to estimate receptor density and affinity (35) .
EGF-induced autophosphorylation of EGF receptor. Sex-specific fetal rabbit lung plasma membranes isolated at day 21 of gestation as described above were used to study EGF-induced autophosphorylation of EGF receptor using a modification of the method of Freidenberg et al. (36) . buffer at 950C for S min. The phosphoproteins were separated by electrophoresis on a 6% polyacrylamide gel (37) and visualized by autoradiography. The band corresponding to the EGF receptor, a 170-kD EGFstimulated phosphoprotein, was cut from the gel and the amount of32p incorporated into the receptor in the presence and absence ofEGF was quantitated in a liquid scintillation counter.
Statistical analysis. The significance of the effects of sex and gestational age on EGF binding were evaluated by two-way analysis of variance (38) . Differences in EGF binding between control and androgentreated groups were evaluated by the unpaired Student's t test. Data from each polyacrylamide gel were normalized by calculating the percent increase in EGF induced incorporation of32p into the EGF receptor as compared with its sex-specific control. Differences in the level of EGF induced autophosphorylation of EGF receptor between males and females were evaluated by the unpaired Student's t test. Values were expressed as either the mean+SD or, where appropriate, the mean±SEM, and were considered statistically significant if the twotailed P values were < 0.05.
Results
Ontogeny ofEGF binding duringfetal lung development. Specific binding of EGF to fetal rabbit lung plasma membranes varied significantly in both sexes with gestation (P < 0.001 ), initially increasing in males (stable in females), reaching maximal binding in both sexes at day 23 ofgestation, then decreasing as term approached (days 25 through 30, Fig. 1) . A sex-specific difference in the binding of EGF to fetal rabbit lung plasma membranes was clearly seen at day 21 ofgestation (Fig.  1) . At this early point in gestation EGF binding to male fetal lung plasma membranes was only 58% of female binding (P < 0.05).
Scatchard analysis (Fig. 2 ) of competitive binding experiments (Fig. 3) performed at day 21 of gestation revealed a significant difference in receptor density between male and female fetal lung plasma membranes. EGF receptor density was significantly lower in males than in females (157±15 versus (Fig. 4 A) (Fig. 4 B) . However, at day 27 of ificantly greater than gestation, there was no significant inhibitory effect of androbinding of EGF to gens on EGF binding (Fig. 4 C) . Scatchard analysis (Fig. 2 (Table I) . Thus, the decreased binding of EGF to androgen-treated female fetal lung plasma membranes at day 21 of gestation was due to a significant decrease in receptor density rather than a decrease in affinity.
The lowest level of EGF binding was seen in the androgentreated males (Fig. 4) . Scatchard analysis of EGF binding again revealed decreased receptor density in fetal rabbit lung plasma membranes isolated from day-21 androgen-treated males as compared with control males (105± 10 versus 157±15 fmol/mg membrane protein, mean+SD, P < 0.01) (Table I) .
Furthermore, EGF receptor binding affinity was not different between day-21 androgen-treated and control male fetal lung tissue (Kd 6.9±2.5 versus 7.1± 1.1 nM, mean±SD) ( Table I) . Thus the decreased binding of EGF to androgen-treated male fetal lung plasma membranes at day 21 ofgestation was caused by a decrease in receptor density rather than to a decrease in affinity.
EGF-induced autophosphorylation ofEGF receptor. EGFinduced autophosphorylation of EGF receptor was measured by the percent increase in 32P incorporation into EGF-stimulated fetal lung plasma membranes as compared with control membranes using sex-specific fetal lung plasma membranes isolated at day 21 ofgestation. EGF-induced autophosphorylation of EGF receptor was significantly greater in females than in males (25.8±4.9% versus 10.9±4.2%, mean±SEM, n = 7, P < 0.05). This difference in EGF-induced autophosphorylation ofthe EGF receptor is consistent with the increased EGF receptor density found at day 21 of gestation in female fetal lung plasma membranes.
Competitive binding with DHT. The binding of [125I] EGF
to female fetal rabbit lung plasma membranes isolated at day 23 ofgestation was measured in the presence ofincreasing concentrations of 5a-dihydrotestosterone or unlabeled EGF (Fig.  5) . The binding of [1251I]EGF was displaced by excess unlabeled EGF, but not by excess DHT. Thus, the EGF receptor is highly specific for EGF and DHT does not compete against EGF for receptor binding.
Discussion
Sex-specific differences in fetal lung development exist, with male fetuses having a delay in lung maturation. Androgens, both endogenous and exogenous, inhibit fetal rabbit lung development (19) . Androgens are known to decrease EGF receptor levels in nonpulmonary tissue, i.e., adult male rat prostate (23, 24) . The data presented here show that androgens decrease pulmonary EGF receptor levels during fetal lung development indicating that one of the mechanisms for the androgen-induced delay in fetal rabbit lung maturation is an inhibition of EGF receptor binding activity.
The level of EGF receptors present in fetal lung was deter- to the fetal lung plasma membrane preparation was specific, since the binding was displaced by excess unlabeled EGF, but not by dihydrotestosterone (Fig. 6) (1, 8, 10) . A potential cause for the curvilinear appearance of the binding data in Fig. 2 B could instead be the existence of negative cooperativity rather than two receptor subtypes (31) Fig. 2 ). The decreased EGF receptor density in males was consistent with their lower level of EGF binding at day 21 of gestation. Although previous studies (40, 41 ) have also identified a high affinity EGF receptor in fetal rabbit lung, they reported no difference in EGF receptor number or density between the sexes. However, these studies were performed with lung tissue isolated from either mature fetuses at term (40) or maturing fetuses at day 27 of gestation (41 ) , not with lung tissue isolated early in development, i.e., day 21 of gestation. Both studies are consistent with our data that showed no sex differences in EGF binding in late gestation. Androgen-induced differences in EGF binding between the sexes occurred when the maximal difference in circulating levels of testosterone was present. The difference in plasma testosterone levels between male and female rabbit fetuses is five-fold at day 21 of gestation when the difference in EGF binding is seen, versus only twofold at day 27 of gestation (26) 23 of gestation in both sexes, blunting the natural rise in EGF binding. However, the androgen-induced inhibition ofEGFreceptorbindingactivity was no longer evident by day 27 of gestation. This is consistent with the natural ontogeny of EGF binding in the fetal rabbit lung which drops by over threefold between day 23 and 27 of gestation (Fig. 1) (Fig. 5 ). This lack of competition for the receptor was seen even with DHT levels in vitro as high as 30 ,qg/ml (l 0-4 M), which greatly exceeds both the normal level of DHT (0.2 ng/ml) in the plasma of male fetal rabbits at day 21 of gestation (26) and the level of DHT in male fetal rabbits treated prenatally with exogenous DHT (0.9 ng/ml) ( 19) .
The use of lung plasma membranes in our binding studies prevents us from addressing the issue of cell-specific effects of androgens on EGF receptor downregulation. The EGF receptor is known to be present in conducting airways (i.e., tracheobronchial epithelium) from both ovine (42) and human fetal lung tissue (43) . The EGF receptor has also been detected in isolated cells from peripheral lung tissue (i.e., isolated adult rat type II cells (44) . More importantly, in terms of fetal lung maturation, the EGF receptor has been detected in situ in prealveolar epithelium from late midtrimester human fetal lung tissue (45) and in human alveolar type II cells from differentiating fetal lung explants (46) . The above immunolocalization studies of EGF receptor in peripheral lung tissue lend further support for a connection between the EGF receptor and fetal lung development.
The present study demonstrates that 5a-dihydrotestosterone decreases EGF receptor density and EGF induced autophosphorylation of EGF receptor in male fetal rabbit lung. This androgen-induced decrease in pulmonary EGF receptor binding activity may be one ofthe mechanisms responsible for the male delay in fetal lung development. We speculate that androgens decrease EGF receptors by decreasing steady-state levels of EGF receptor mRNA through either decreased transcription or increased degradation ofmessage. Other hormones have been shown to affect levels of EGF receptor mRNA or EGF binding. Thyroid hormone increases EGF receptor mRNA levels in adult mouse liver (47, 48) and the absence of thyroid hormones (congenital hypothyroidism) delays EGF receptor binding in neonatal mouse liver (49) . Similarly, estrogens increase EGF receptor mRNA levels in mouse uterine tissue (50) . Future efforts will be directed towards evaluating the hormonal regulation of EGF receptor mRNA levels during fetal lung development.
